Development of a potent class of small molecule inhibitors of the MDM2-p53 protein-protein interaction

被引：1

作者：

Fazal, Lynsey ^{[1
]}

Ahn, Maria ^{[1
]}

Bevan, Luke ^{[1
]}

Buck, Ildiko ^{[1
]}

Castro, Juan ^{[1
]}

Chessari, Gianni ^{[1
]}

Cons, Ben ^{[1
]}

Hearn, Keisha ^{[1
]}

Howard, Steven ^{[1
]}

Johnson, Chris ^{[1
]}

Reeks, Judith ^{[1
]}

Tamanini, Emiliano ^{[1
]}

Thompson, Neil ^{[1
]}

Walton, Hugh ^{[1
]}

Williams, Pamela ^{[1
]}

Bawn, Ruth H. ^{[2
]}

Blackburn, Tim J. ^{[2
]}

Cano, Celine ^{[2
]}

Cully, Sarah J. ^{[2
]}

Golding, Bernard ^{[2
]}

Griffin, Roger ^{[2
]}

Haggerty, Karen ^{[2
]}

Hardcastle, Ian ^{[2
]}

Newell, Herbie ^{[2
]}

Noble, Martin ^{[2
]}

Thomas, Huw ^{[2
]}

Willmore, Elaine ^{[2
]}

Zhao, Yan ^{[2
]}

Wedge, Steve ^{[2
]}

机构：

[1] Astex Therapeut, Cambridge, England

[2] Nothern Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England

来源：

CANCER RESEARCH | 2018年 / 78卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2018-1652

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1652

引用

页数：3

共 50 条

[1] Selective and Potent Morpholinone Inhibitors of the MDM2-p53 Protein-Protein Interaction
Gonzalez, Ana Z.
Eksterowicz, John
Bartberger, Michael D.
Beck, Hilary P.
Canon, Jude
Chen, Ada
Chow, David
Duquette, Jason
Fox, Brian M.
Fu, Jiasheng
Huang, Xin
Houze, Jonathan B.
Jin, Lixia
Li, Yihong
Li, Zhihong
Ling, Yun
Lo, Mei-Chu
Long, Alexander M.
McGee, Lawrence R.
McIntosh, Joel
McMinn, Dustin L.
Oliner, Jonathan D.
Osgood, Tao
Rew, Yosup
Saiki, Anne Y.
Shaffer, Paul
Wortman, Sarah
Yakowec, Peter
Yan, Xuelei
Ye, Qiuping
Yu, Dongyin
Zhao, Xiaoning
Zhou, Jing
Olson, Steven H.
Medina, Julio C.
Sun, Daqing
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (06) : 2472 - 2488
[2] Identification of substituted isoindolinones as potent inhibitors of the MDM2-p53 protein-protein interaction
Watson, Anna
Liu, Junfeng
Armstrong, Elizabeth
Blackburn, Timothy
Endicott, Jane A.
Golding, Bernard T.
Griffin, Roger J.
Lu, Xiaohong
Newell, David R.
Noble, Martin E. M.
Riedinger, Christiane
Lunec, John
Hardcastle, Ian R.
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
[3] Small-molecule inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffold
Hardcastle, Ian R.
Ahmed, Shafiq U.
Atkins, Helen
Farnie, Gillian
Golding, Bernard T.
Griffin, Roger J.
Guyenne, Sabrina
Hutton, Claire
Kallblad, Per
Kemp, Stuart J.
Kitching, Martin S.
Newell, David R.
Norbedo, Stefano
Northen, Julian S.
Reid, Rebecca J.
Saravanan, K.
Willems, Henriette M. G.
Lunec, John
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (21) : 6209 - 6221
[4] Discovery of MDM2-p53 and MDM4-p53 protein-protein interactions small molecule dual inhibitors
Espadinha, Margarida
Lopes, Elizabeth A.
Marques, Vanda
Amaral, Joana D.
dos Santos, Daniel J. V. A.
Mori, Mattia
Daniele, Simona
Piccarducci, Rebecca
Zappelli, Elisa
Martini, Claudia
Rodrigues, Cecilia M. P.
Santos, Maria M. M.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 241
[5] Discovery of sulfonamide-piperidinones as potent inhibitors of the MDM2-p53 protein-protein interaction
Li, Zhihong
Fu, Jiasheng
Rew, Yosup
Gribble, Michael W.
Canon, Jude
Chen, Ada
Eksterowicz, John
Huang, Xin
Jin, Lixia
Lo, Mei-Chu
McGee, Lawrence R.
Osgood, Tao
Saiki, Anne Y.
Shaffer, Paul
Sun, Daqing
Wortman, Sarah
Ye, Qiuping
Yu, Dongyin
Zhao, Xiaoning
Zhou, Jing
Oliner, Jonathan D.
Olson, Steve H.
Medina, Julio C.
CANCER RESEARCH, 2015, 75
[6] Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment
Zhao, Yujun
Aguilar, Angelo
Bernard, Denzil
Wang, Shaomeng
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (03) : 1038 - 1052
[7] Isoindolinone based inhibitors of the MDM2-p53 protein-protein interaction
Kemp, SJ
Hardcastle, IR
Ahmed, SU
Atatreh, NA
Barrett, P
Endicott, JA
Golding, BT
Griffin, RJ
Gruber, J
Hutton, C
Lunec, J
Noble, MEM
Reid, RJ
Riedinger, C
Smyth, LA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2735 - U2736
[8] Small molecule protein-protein inhibitors for the p53-MDM2 interaction
Dudkina, Anna S.
Lindsley, Craig W.
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (10) : 952 - 960
[9] The development of piperidinones as potent MDM2-P53 protein - protein interaction inhibitors for cancer therapy
Liao, Guochao
Yang, Deying
Ma, Leilei
Li, Wenwei
Hu, Liqin
Zeng, Liming
Wu, Peng
Duan, Lixin
Liu, Zhongqiu
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 159 : 1 - 9
[10] Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction
Hardcastle, IR
Ahmed, SU
Atkins, H
Calvert, AH
Curtin, NJ
Farnie, G
Golding, BT
Griffin, RJ
Guyenne, S
Hutton, C
Källbad, P
Kemp, SJ
Kitching, MS
Newell, DR
Norbedo, S
Northen, JS
Reid, RJ
Saravanan, K
Willems, HMG
Lunec, J
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (05) : 1515 - 1520

← 1 2 3 4 5 →